EnteroMedics Inflates Neuromod-Obesity Offering With ReShape Balloon

The deal, worth $61m in cash and stock, will add ReShape's Dual Weight Loss Balloon to EnteroMedics' vBloc neurometabolic therapy and Gastric Vest System for the treatment of obesity.